Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/251280 stock hub

XKON/251280 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/251280is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.3B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/251280

In the news

Latest news · XKON/251280

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-28.6

P25 n/aP50 n/aP75 n/a

ROIC-10.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/251280 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

KRW

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 6.3B
Price	KRW 1,795
Price currency	KRW
Sic	2836
Symbol	xkon/251280
Website	https://www.angiolab.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-18.93%
FCF yield	-1.68%
P/B ratio	1.76x
P/S ratio	8.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-101.91%
EBITDA Margin	-68.83%
Gross margin	48.19%
Gross Profit	KRW 338.6M
Net Income	KRW -1.2B
Pretax Margin	-168.87%
Profit Margin	-168.87%
ROA	-8.55
ROCE	-18
ROE	-28.58
ROIC	-10.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-69.81%
Cagr3y	-38.95%
Cagr5y	-31.67%
Revenue Growth	-20.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.13
Assets	KRW 4.4B
Cash	KRW 2.5B
Current Assets	KRW 2.8B
Current Liabilities	KRW 419M
Equity	KRW 3.6B
Interest Coverage	-775.8
Liabilities	KRW 839.3M
Long Term Assets	KRW 1.6B
Long Term Liabilities	KRW 420.3M
Net Cash	KRW 2.5B
Net Cash By Market Cap	KRW 39.65
Net Debt Equity	KRW -0.7
Tangible Book Value	KRW 2.9B
Tangible Book Value Per Share	KRW 3,365
WACC	1.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.72
Inventory Turnover	1.29
Net Working Capital	KRW -87M
Quick ratio	6.05
Working Capital	KRW 2.4B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-69.78%
200-day SMA	3,162.2
3Y total return	-77.25%
50-day SMA	2,218.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.1%
All Time High	25,800
All Time High Change	-93.04%
All Time High Date	2018-10-29
All Time Low	1,523
All Time Low Change	17.86%
All Time Low Date	2026-05-06
ATR	195.2
Beta	-0.48
Beta1y	0.42
Beta2y	-0.07
Ch YTD	-27.03
High	1,800
High52	5,940
High52 Date	2025-05-08
High52ch	-69.78%
Low	1,534
Low52	1,523
Low52 Date	2026-05-06
Low52ch	17.86%
Ma50ch	-19.08%
Price vs 200-day SMA	-43.24%
RSI	34.37
RSI Monthly	28.02
RSI Weekly	29.22
Sharpe ratio	-1.77x
Sortino ratio	-2.07
Tr YTD	-27.03
Tr1m	-17.66%
Tr1w	1.41%
Tr3m	-27.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -716.1M
Operating margin	-101.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,771,259%
Net Borrowing	-600,000,000
Shares Insiders	35.05%
Shares Institutions	4.58%
Shares Out	3,491,870

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -105.3M
Average Volume	11,516.05x
Bv Per Share	3,675.8
CAPEX	KRW -22.6M
Ch1m	-17.66
Ch1w	1.41
Ch1y	-69.78
Ch3m	-27.91
Ch3y	-77.25
Ch5y	-85.1
Ch6m	-57.26
Change	6.59%
Change From Open	12.19
Close	1,684
Days Gap	-4.99
Depreciation Amortization	232,441,000
Dollar Volume	19,741,410
EBIT	KRW -716.1M
EBITDA	KRW -483.6M
EPS	KRW -1,356
F Score	1
FCF	KRW -105.3M
FCF Per Share	KRW -30.16
Financing CF	-600,000,000
Fiscal Year End	December
Founded	1,999
Investing CF	1,230,672,000
Is Primary Listing	1
Ma150	2,850.8
Ma150ch	-37.04%
Ma20	2,097.9
Ma20ch	-14.44%
Net CF	547,943,000
Open	1,600
Position In Range	98.12
Ppne	18,107,000
Price Date	2026-05-08
Ptbv Ratio	2.13
Relative Volume	0.96x
Revenue	702,621,000x
Tr6m	-57.26%
Volume	10,998
Z Score	-0.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/251280 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/251280 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/251280?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.6%

Share of float held by funds and institutions

Insider ownership

+35.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/251280 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.4

Neutral momentum band

Price vs 200-day MA

-43.2%

50/200-day relationship not available

Beta (5Y)

-0.48

Less volatile than the market

Sharpe ratio

-1.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/251280

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/251280 stock rating?

xkon/251280 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/251280 analysis?

The full report lives at /stocks/xkon/251280/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/251280?

The latest report frames xkon/251280 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/251280 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.